PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

Mishustin: 90% of Essential Medicines Should Be Produced in Russia

According to the Prime Minister, this goal will be pursued as part of the national project “New Health Preservation Technologies.”

The share of domestically produced medicines from the list of essential and vital drugs (EVDL) in Russia should increase to 90% by 2030, Russian Prime Minister Mikhail Mishustin announced.

He noted that this effort will be conducted within the framework of the national project “New Health Preservation Technologies.”

“Activities under the national project ‘New Health Preservation Technologies’ will help expand the use of biomedical technologies, regenerative medicine methods, and improve access for citizens to advanced approaches in prevention and treatment. The share of domestically produced essential and vital medicines should increase to 90%,” said the Prime Minister while addressing the National Projects Council.

In April, during a report on the government’s work in 2023, Mishustin stated that the current share of domestically produced medicines from the EVDL list stands at 80%.

Source: TASS, December 5, 2024

Current news

  • March 10, 2026

    Public Procurement of Medicines in Russia Reached 1 Trillion Rubles in 2025

    Public procurement of medicines in Russia totaled 1 trillion rubles in 2025, representing a 26%…

  • March 10, 2026

    Retail Pharmaceutical Market Value Increased by 13.3% in 2025

    The value of Russia’s retail pharmaceutical market reached 1.83 trillion rubles in 2025, marking a…

  • March 10, 2026

    New Molecules Synthesized in Russia for Next-Generation Medicines

    The compounds could help develop antimicrobial, anticancer, and anti-inflammatory drugs, according to the press service…

  • March 10, 2026

    DSM Group Presents Top 10 Russian Pharmaceutical Distributors

    According to data from DSM Group, the pharmaceutical market volume at distributor prices reached 2.87…

  • March 10, 2026

    Russia Plans to Halve Dependence on Imports of Critical Biocomponents by 2030

    The strategy for developing the bioeconomy sector предусматривает создание новых рынков, включая синтетическую биологию, промышленную…

LLC “BioJet”. all rights reserved

  • Legal information